Burrows Scott L Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
7
Insider Sells Sum
$1.07M

Insider Activity of Burrows Scott L

According to the SEC Form 4 filings, Burrows Scott L, being in a position of

  1. Chief Financial Officer at Spyre Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 110732 shares for $9.12M,
    over all time since 2024-09-03, has bought 0 shares, and sold 147691 share for $9.95M.

Biography of Burrows Scott L

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $9,124,22011100

Comparison of Insiders on Amount of Buys and Sells

2026-10-01SaleSpyre Therapeutics, Inc.
SYRE
Chief Financial Officer
7,500
0.0088%
$91.83$688,756+1.63%
2026-09-30SaleSpyre Therapeutics, Inc.
SYRE
Chief Financial Officer
17,500
0.0203%
$89.89$1.57M+2.06%
2026-09-02SaleSpyre Therapeutics, Inc.
SYRE
Chief Financial Officer
18,232
0.0215%
$89.35$1.63M+3.68%
2026-09-01SaleSpyre Therapeutics, Inc.
SYRE
Chief Financial Officer
7,500
0.0085%
$87.31$654,792+1.8%
2026-08-03SaleSpyre Therapeutics, Inc.
SYRE
Chief Financial Officer
7,500
0.0022%
$95.57$716,771-3.72%
2026-07-01SaleSpyre Therapeutics, Inc.
SYRE
Chief Financial Officer
7,500
0.0123%
$87.74$658,040+5.31%
2026-06-25SaleSpyre Therapeutics, Inc.
SYRE
Chief Financial Officer
15,000
0.0244%
$87.13$1.31M+4.83%
2026-06-01SaleSpyre Therapeutics, Inc.
SYRE
Chief Financial Officer
7,500
0.0125%
$71.06$532,937+29.98%
2026-05-01SaleSpyre Therapeutics, Inc.
SYRE
Chief Financial Officer
12,500
0.0205%
$71.37$892,125+29.71%
2026-04-01SaleSpyre Therapeutics, Inc.
SYRE
Chief Financial Officer
7,500
0.0125%
$49.34$370,076+80.65%
2026-03-03SaleSpyre Therapeutics, Inc.
SYRE
Chief Financial Officer
2,500
0.004%
$40.65$101,620+114.24%
2025-09-02SaleSpyre Therapeutics, Inc.
SYRE
Chief Financial Officer
18,428
0.0298%
$16.26$299,639+149.76%
2024-09-03SaleSpyre Therapeutics, Inc.
SYRE
Chief Financial Officer
18,531
0.0313%
$28.17$522,074-28.8%
2023-03-06SaleArcutis Biotherapeutics, Inc.
ARQT
Chief Financial Officer
291
0.0005%
$15.26$4,442-43.29%
2023-03-02SaleArcutis Biotherapeutics, Inc.
ARQT
Chief Financial Officer
1,434
0.0023%
$15.83$22,696-48.1%
2023-02-28SaleArcutis Biotherapeutics, Inc.
ARQT
Chief Financial Officer
416
0.0007%
$16.17$6,725-49.26%
2022-03-03SaleArcutis Biotherapeutics, Inc.
ARQT
Chief Financial Officer
10
<0.0001%
$16.44$164+6.62%
2022-03-01SaleArcutis Biotherapeutics, Inc.
ARQT
Chief Financial Officer
420
0.0008%
$17.75$7,456+7.66%
2021-12-27SaleArcutis Biotherapeutics, Inc.
ARQT
Chief Financial Officer
25,120
0.0497%
$20.07$504,279-5.19%
Total: 19
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.